Montag & Associates’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-11,787
Closed -$160K 306
2020
Q2
$160K Hold
11,787
0.01% 288
2020
Q1
$148K Hold
11,787
0.01% 272
2019
Q4
$208K Sell
11,787
-236
-2% -$4.2K 0.02% 291
2019
Q3
$214K Hold
12,023
0.02% 286
2019
Q2
$212K Buy
12,023
+236
+2% +$4.16K 0.02% 293
2019
Q1
$212K Hold
11,787
0.02% 290
2018
Q4
$190K Hold
11,787
0.02% 276
2018
Q3
$233K Hold
11,787
0.02% 300
2018
Q2
$218K Buy
+11,787
New +$222K 0.02% 266

Other funds holding DIAX

Montag & Associates's DIAX Position: Q3 2020 in Review

Montag & Associates sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q3 2020, closing a stake of 11,787 shares — an estimated $160K sold.

Montag & Associates first reported a position in DIAX in Q2 2018 and held it in 9 quarters. The position peaked at $233K in Q3 2018. 82 funds tracked by Wall St. Rank hold DIAX as of Q3 2020.

  • Montag & Associates reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q3 2020 after selling out during the quarter.
  • Montag & Associates sold 11,787 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q3 2020, an estimated $160K.
  • Montag & Associates first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q2 2018 and held it in 9 quarters.
  • Montag & Associates's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $233K in Q3 2018.
  • 82 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q3 2020.

Based on Montag & Associates's 13F filing for Q3 2020, filed 12 Nov 2020.